METTL5- tRNA methyltransferase 112 (TRMT112)-mediated 18S rRNA N6-methyl adenosine (m6A) modification promotes HCC growth and metastasis in vitro and in vivo. The gene discussed is METTL5; the disease is hepatocellular carcinoma.